longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Guardian Pharmacy Services

GRDN

41.2101.39% ( -0.580 )
Closed: Sep 25, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 39.61, within the reasonable range, cheaper than 79.69% of the time in the past 1 years, and the industry ranks 20/74, the industry Median --.

39.61xP/E
$41.21Stock price
$1.04Earnings per share
39.61xP/E
Stock price$41.21Earnings per share$1.04

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
47.94x
Typical range
39.61x–109.40x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
CVSUSCVS Health
23.31x394.45%$113.99B
DGXUSQuest Diagnostics
24.65x16.13%$26.08B
LHUSLabcorp
25.05x33.20%$25.11B
BTSGUSBrightSpring Health Services
30.60x86.70%$11.20B
CHEUSChemed
27.22x26.94%$7.49B
CRVLUSCorVel
32.56x--$3.75B
GRDNUSGuardian Pharmacy Services
39.61x56.67%$2.61B
ADUSUSAddus Homecare
20.07x18.27%$2.11B
VMDUSViemed Healthcare
23.41x11.71%$339.37M
INFUUSInfusystem
29.63x37.64%$253.15M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.